Skip to main navigation Skip to search Skip to main content

SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight

  • Jyoti Gupta
  • , Md Zubbair Malik
  • , Maya Chaturvedi
  • , Mohit Mishra
  • , Surbhi Kriti Mishra
  • , Abhinav Grover
  • , Ashwini Kumar Ray
  • , Rupesh Chaturvedi

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Abstract

The Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is related with the COVID-19 pandemic. Recent spike protein variations have had an effect on the transmission of the virus. In addition to ACE-2, spike proteins can employ DC-SIGN and its analogous receptor, DC-SIGNR, for host evasion. Spike variations in the DC-SIGN interaction region and role of DC-SIGN in immune evasion have not been well defined. To understand the spike protein variations and their binding mode, phylogenetic analysis of the complete GISAID (Global Initiative for Sharing Avian Influenza Data) data of the SARS-CoV-2 spike protein was considered. In addition, an in silico knockout network evaluation of the SARS-CoV-2 single-cell transcriptome was conducted to determine the key role of DC-SIGN/R in immunological dysregulation. Within the DC-SIGN-interacting region of the SARS-CoV spike protein, the spike protein of SARS-CoV-2 displayed remarkable similarity to the SARS-CoV spike protein. Surprisingly, the phylogenetic analysis revealed that the SARS-CoV-2’s spike exhibited significantly diverse variants in the DC-SIGN interaction domain, which altered the frequency of these variants. The variation within the DC-SIGN-interacting domain of spike proteins affected the binding of a limited number of variants with DC-SIGN and DC-SIGNR and affected their evolution. MMGBSA binding free energies evaluation differed for variants from those of the wild type, suggesting the influence of substitution mutations on the interaction pattern. In silico knockout network analysis of the single-cell transcriptome of Bronchoalveolar Lavage and peripheral blood mononuclear cells revealed that SARS-CoV-2 altered DC-SIGN/R signaling. Early surveillance of diverse SARS-CoV-2 strains could preclude a worsening of the pandemic and facilitate the development of an optimum vaccine against variations. The spike Receptor Binding Domain genetic variants are thought to boost SARS CoV-2 immune evasion, resulting in its higher longevity.

Original languageEnglish
Pages (from-to)278-296
Number of pages19
JournalVirusDisease
Volume34
Issue number2
DOIs
StatePublished - Jun 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • DC-SIGN
  • DC-SIGN interacting region
  • DC-SIGN signalosome
  • DC-SIGNR
  • Immune dysregulation in silico
  • Mapiya
  • MMGBSA
  • SARS COV-2
  • Single cell transcriptome
  • Spike protein variant

Funding Agency

  • Kuwait Foundation for the Advancement of Sciences

Fingerprint

Dive into the research topics of 'SARS CoV-2 spike protein variants exploit DC-SIGN/DC-SIGNR receptor for evolution and severity: an in-silico insight'. Together they form a unique fingerprint.

Cite this